Coverage
-
May 12, 2015
Consumers accusing Allergan Inc. and its subsidiary SkinMedica Inc. of concealing the cancer risks of anti-aging creams made from human foreskin cells, cow blood and other biological materials moved for class certification in California federal court on Monday.
2 other articles on this case.
View all »